Krystal Biotech, Inc. - Common Stock — États financiers (NASDAQ:KRYS) | MetaTrader

Afficher le graphique complet Full chart

Nouvelles

Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock

Krystal Biotech, Inc. (KRYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

L’action Krystal Biotech atteint un sommet historique à 315,68 $

This Profitable Biotech Stealthily Climbs Into A Buy Zone

Krystal Biotech: Vyjuvek Is Not The Primary Asset (NASDAQ:KRYS)

Rocket Lab Soars 34%, Leads 10 Hot Prospects To IBD Best Stock Screens

Krystal Biotech, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KRYS) 2026-05-06

Krystal Biotech Analysts Boost Their Forecasts Following Upbeat Q1 Results - Krystal Biotech (NASDAQ:KRYS

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

BofA réduit l’objectif de cours de Krystal Biotech sur fond de changement de mix de revenus

Krystal Biotech dépasse les attentes au T1 2026

Krystal Biotech, Inc. (KRYS) Tops Q1 Earnings and Revenue Estimates